Back

LDL treatment-years: a new paradigm for cardiovascular risk reduction

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: What's new about LDL cholesterol? Lipids ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Elizabeth Epstein

Scripps Clinic Medical Group, Inc., La Jolla (United States of America)

5 More presentations in this session

Presentation thumbnail
LDL-cholesterol variability and cardiovascular follow-Up in sitosterolemia
Doctor F. Del Castanhel (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Inequalities in cholesterol management for patients with cardiovascular disease: findings from CVDPREVENT
Mr M. White (GB)
Abstract Slides
Presentation thumbnail
LDL-C reduction and residual cardiovascular risk in heterozygous familial hypercholesterolemia: a matched cohort study in South Wales
Doctor N. Genedy (Cardiff, GB) Doctor S. Zouwail (Cardiff, GB)
Abstract Slides
Presentation thumbnail
Low-density lipoprotein cholesterol, coronary plaque burden, and cardiovascular risk in individuals beyond 75 years of age
Doctor M. Andersen (Aarhus, DK)
Abstract Slides
Presentation thumbnail
Apolipoprotein B outperforms low density lipoprotein particle number as a marker of cardiovascular risk in the UK biobank
Doctor E. Epstein (La Jolla, US)
Abstract Slides

Access the full session

Session thumbnail
What's new about LDL cholesterol?
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Congress Presentation
Lipid control in cardiovascular patients
thumbnail
Congress Presentation
Lipidomics to fine-tune cardiovascular risk prediction and personalised treatment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources